Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-16

Clinical Trial Update: The Study of Minocycline for Negative and Cognitive Symptoms in Schizophrenia [Phase 4]

View source ↗

Summary

A completed Phase 4 clinical trial evaluating minocycline for negative and cognitive symptoms in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Minocycline (minocycline)

Snippet

Sponsor: Central South University | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED